Neurocrine Biosciences, Inc. v. Teva Pharmaceuticals, Inc. et al > Summary
Court Case Number 1:22-cv-00965
Filing Date Jul 22, 2022
Termination Date Mar 29, 2023
Court Delaware District Court
Status Judgment - Judgment on Consent
JudgesMaryellen Noreika
Plaintiff
Defendant
Plaintiff Attorneys
2Neurocrine Biosciences
Attorney Name: Steven J. Balick
Ashby & Geddes
Neurocrine Biosciences
Attorney Name: Andrew C. Mayo
Ashby & Geddes
Defendant Attorneys
Teva Pharmaceuticals
Attorney Name: Nathan R. Hoeschen
Shaw Keller LLP
Counter Defendant
4Neurocrine Biosciences
Attorney Name: Steven J. Balick
Ashby & Geddes
Neurocrine Biosciences
Attorney Name: Andrew C. Mayo
Ashby & Geddes
Neurocrine Biosciences
Attorney Name: Steven J. Balick
Ashby & Geddes
Neurocrine Biosciences
Attorney Name: Andrew C. Mayo
Ashby & Geddes
Counter Claimant
6Teva Pharmaceuticals
Attorney Name: Nathan R. Hoeschen
Shaw Keller LLP
Teva Pharmaceuticals
Attorney Name: Nathan R. Hoeschen
Shaw Keller LLP
Teva Pharmaceuticals
Attorney Name: Nathan R. Hoeschen
Shaw Keller LLP
Teva Pharmaceuticals
Attorney Name: Nathan R. Hoeschen
Shaw Keller LLP
Teva Pharmaceuticals
Attorney Name: Nathan R. Hoeschen
Shaw Keller LLP
Teva Pharmaceuticals
Attorney Name: Nathan R. Hoeschen
Shaw Keller LLP